ArticleCNS neuroscience & therapeutics2025
Electroacupuncture Attenuates High-Fat Diet-Exacerbated Alzheimer's Pathology by Enhancing TFEB/TFE3-Mediated Autophagic Clearance of Tau and NLRP3 Inflammasome in 3xTg Mice.
Article in CNS neuroscience & therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Evaluating the potential of acupuncture for Alzheimer's disease treatment: A meta-analysis and systematic review of mouse model studies.Translational psychiatry · 2026Pooled it
- The Glial Autophagy-Lysosomal-Inflammation Axis in Alzheimer's Disease: a Unifying Mechanistic Framework.Molecular neurobiology · 2026Review
- AAV Vector-Mediated Modulation of Signaling Pathways in Neurological Disorders: Insights From Cellular, Animal, and Human Studies.Cell biochemistry and function · 2026Review
- Electroacupuncture Ameliorates Learning and Memory Deficits in Vascular Cognitive Impairment Rats Through Activation of the Supramammillary Nucleus-Dentate Gyrus Circuit.CNS neuroscience & therapeutics · 2026Article
- Physical exercise in combination with audiovisual stimulation alleviates cognitive and affective impairments in Alzheimer's disease model mice via restoring lysosomal membrane integrity.Alzheimer's research & therapy · 2026Article
- NDST3 suppression restores lysosomal acidification and ameliorates amyloid-β and MAPT/tau pathology in Alzheimer's disease.Translational neurodegeneration · 2026Article
- Unraveling the Effects ofInternational journal of molecular sciences · 2025Review
- Electroacupuncture Attenuates High-Fat Diet-Exacerbated Alzheimer's Pathology by Enhancing TFEB/TFE3-Mediated Autophagic Clearance of Tau and NLRP3 Inflammasome in 3xTg Mice.CNS neuroscience & therapeutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundAlzheimer's disease (AD) pathology is increasingly linked to metabolic disturbances induced by high-fat diets (HFD), with both autophagy-lysosomal pathway (ALP) dysfunction and activation of the NLRP3 inflammasome emerging as key pathological mechanisms. This study introduces a novel approach using electroacupuncture (EA) to mitigate HFD-accelerated AD pathology, focusing on the regulatory role of transcription factors TFEB and TFE3 in ALP and their potential modulation by EA.
methods3xTg-AD mice were fed either an HFD or a standard diet for 16 weeks, followed by EA treatment at the ST36 acupoint. AAV-mediated hippocampal knockdown of TFEB and TFE3 was performed using shRNA constructs. Cognitive performance was evaluated with the Morris water maze (MWM) and Y-maze tests. Molecular analyses, including immunoblotting and immunohistochemistry, were conducted to examine the impact of EA on NLRP3 inflammasome activation, ALP dynamics, and the involvement of TFEB and TFE3 in modulating these pathways within the brain.
resultsHFD feeding significantly exacerbated Tau pathology and NLRP3 inflammasome activation in 3xTg-AD mice, leading to pronounced cognitive deficits. Notably, EA-ST36 intervention reversed these pathological effects, enhancing memory function and reducing both Tau aggregation and NLRP3 inflammasome activation. Mechanistic insights revealed that EA-ST36 activated TFEB and TFE3 by modulating the MTOR/ULK1 signaling pathway, thereby enhancing autophagic clearance of NLRP3 inflammasome components and Tau aggregates.
conclusionThis study proposes EA-ST36 as a promising therapeutic strategy for counteracting HFD-induced AD pathology by activating TFEB/TFE3-driven autophagic pathways, thereby enhancing the clearance of toxic protein aggregates and inflammasome components. These findings advance our understanding of EA's molecular mechanisms in AD therapy, offering a novel, nonpharmacological approach for mitigating diet-induced exacerbation of neurodegenerative processes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.